Harrow, Inc. (NASDAQ:HROW) is a company that has recently caught the attention of investors. On September 29, 2025, Thomas Flaten from Lake Street set a price target of $70 for HROW. At the time, the stock was priced at $47.10, suggesting a potential increase of about 48.62%. This optimistic outlook reflects confidence in Harrow's future performance.Harrow recently held its Analyst/Investor Day on September 26, 2025. Key figures like Michael Biega, Mark Baum, and Andrew Boll shared insights into the company ...

US Gold Corp (USAU) closed the last trading session at $15.12, gaining 13.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $19.5 indicates a 29% upside potential.The mean estimate comprises three short-term price targets with a standard deviation of $4.27. While the lowest estimate of $15.00 indicates a 0.8% decline from the current price level, the most optimistic analyst expect ...

Shares of Photronics (PLAB) have gained 11.1% over the past four weeks to close the last trading session at $24.73, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $31.65 indicates a potential upside of 28%.The mean estimate comprises three short-term price targets with a standard deviation of $1.51. While the lowest estimate of $30.00 indicates a 21.3% increase from the current ...

Shares of MBX Biosciences, Inc. (MBX) have gained 44% over the past four weeks to close the last trading session at $20, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $37.71 indicates a potential upside of 88.6%.The mean estimate comprises seven short-term price targets with a standard deviation of $4.23. While the lowest estimate of $30.00 indicates a 50% increase from the cu ...

Edgewise Therapeutics, Inc. (EWTX) closed the last trading session at $13.89, gaining 0.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $39.17 indicates an 182% upside potential.The mean estimate comprises 12 short-term price targets with a standard deviation of $12.96. While the lowest estimate of $14.00 indicates a 0.8% increase from the current price level, the most optimisti ...

公司业务与行业定位 - 公司专注于商用洗衣和干洗设备的分销与服务 在酒店、医疗保健和教育等多个行业提供必要服务[1] - 公司在商用洗衣设备领域与其他企业竞争 通过战略增长和客户服务维持市场地位[1] 股价表现与市场数据 - 当前股价为27.99美元 较前日小幅上涨0.74%或0.205美元[3] - 当日交易区间为27.96美元至28.39美元 显示一定波动性[3] - 过去一年股价最高达29.29美元 最低为14.99美元 市场表现存在波动[3] - 公司市值约为3.5718亿美元 在行业中具有显著地位[3] - 当前交易量仅为1,409股 交易活动相对有限[4] 分析师观点与价格目标 - D A Davidson分析师Michael Shlisky设定33美元目标价 较当前价格存在约17.65%上涨空间[2][5] - 这一乐观预期出现在公司第四季度2025财报电话会议之后[2] 财务披露与战略方向 - 公司于2025年9月10日举行第四季度2025财报电话会议 CEO Henry Nahmad讨论了财务业绩和未来计划[2] - 财报电话会议揭示了战略增长计划 重点是在商用洗衣设备领域维持市场地位[5]

Mission Produce, Inc. (AVO) closed the last trading session at $12.85, gaining 3.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $17.33 indicates a 34.9% upside potential.The mean estimate comprises three short-term price targets with a standard deviation of $0.58. While the lowest estimate of $17.00 indicates a 32.3% increase from the current price level, the most optimistic an ...

股价表现与目标价 - 公司股价在最近四周上涨26.2%至23.88美元 但华尔街分析师平均目标价36.33美元显示仍有52.1%上涨空间[1] - 三个短期目标价的标准差为1.53美元 最低目标价35美元预示46.6%涨幅 最高目标价38美元预示59.1%涨幅[2] - 分析师目标价共识度较高（低标准差）表明对股价变动方向和幅度存在高度共识[9] 盈利预测修正 - 过去30天内有两项年度盈利预测上调且无下调 推动Zacks共识预期上升4%[12] - 分析师对盈利前景乐观情绪增强 盈利预测上调趋势与短期股价走势存在强相关性[11] - 公司获Zacks评级第2级（买入） 位列4000多只股票前20% 该评级基于盈利预期相关四项因素[13] 目标价可靠性分析 - 学术研究表明目标价常误导投资者 分析师设定的目标价很少能准确预示实际股价走向[7] - 华尔街分析师可能因业务激励（如维护客户关系）设定过度乐观的目标价[8] - 虽然目标价方向性指引具有参考价值 但仅凭此做投资决策可能导致投资回报率不及预期[10] 投资参考依据 - 盈利预测修正趋势比目标价更能可靠预测股价上涨潜力[4] - 低标准差目标价集群可作为研究基本面驱动力的起点 但非绝对预测指标[9] - Zacks评级系统的外部审计记录显示该评级对短期上涨潜力具有结论性指示作用[13]

Shares of Knightscope, Inc. (KSCP) have gained 4.7% over the past four weeks to close the last trading session at $5.82, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $15.33 indicates a potential upside of 163.4%.The mean estimate comprises three short-term price targets with a standard deviation of $9.45. While the lowest estimate of $8.00 indicates a 37.5% increase from the ...

股价表现与目标价 - A-Mark Precious Metals（AMRK）股价在过去四周上涨7.6%至25.01美元 但华尔街分析师给出的短期平均目标价40.5美元意味着潜在61.9%上涨空间 [1] - 四个目标价区间为29美元至63美元 最低目标价仍有16%涨幅 最高目标价对应151.9%涨幅 标准差为15.8美元反映分析师观点差异程度 [2] 目标价可靠性分析 - 实证研究表明目标价常误导投资者 分析师因业务关系倾向于设定过度乐观的目标价 [7][8] - 较低的标准差表明分析师对股价变动方向和幅度有较高共识 可作为进一步研究基础 [9] - 投资者不应完全依赖目标价做决策 需保持审慎态度 [10] 盈利预测修正 - 分析师一致上调EPS预测 近期30天内出现一次正面修正且无负面修正 推动Zacks共识预期上调26.1% [11][12] - 盈利预测修正趋势与短期股价走势存在强相关性 成为看涨的合理依据 [11] 投资评级表现 - AMRK获Zacks排名第一（强烈买入） 位列基于盈利预期四因素排名的4000余只股票前5% [13] - 该排名经过外部审计验证 对短期潜在上涨空间具有结论性指示作用 [13]